Dr. Eric Crombez
Medical Director, Ultragenyx

Dr. Crombez updates us on Ultragenyx’s CYPRUS2+ study and clinical trial, a promising new gene therapy treatment for Wilson disease. You'll learn details about the study, its timeline and potential to restore ATP7B function in the liver. The CYPRUS2+ study continues to enroll adults living with Wilson disease who are currently wellmanaged on standard of care.

For more information email [email protected]
For more information about this trial, visit www.wilsondisease.org under News, Ultragenyx Disease Update August 2023.